Bio-imaging by functional nano-particles of nano to macro scale
IFMBE Proceedings, ISSN: 1680-0737, Vol: 23, Page: 2272-2274
2009
- 2Citations
- 11Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Conference Paper Description
Nano-materials are expected to be used for medical applications such as research on pharmacokinetics and novel therapeutic agents. Their acute toxicity should be examined and systemic distribution of the nano-materials should also be estimated. We established a high resolution in vivo 3D microscopic system for a novel fluorescence imaging method at single molecular level. We measured in vivo movement of CdSe nano-particles (quantum dots (QDs)) conjugated with monoclonal anti-HER2 antibody (Trastuzumab) in tumor vessel to breast cancer cells. The HER2 protein expressed in cancer cells and its in vivo dynamics were visualized by QDs at nano-scale. It suggests future utilization of the system to improve drug delivery system to target the primary and metastatic tumors for made to order treatment. We also describe a novel contrast medium for X-ray and its distribution in organs. Nano-sized silica coated silver iodide beads exhibited contrast enhancementin the tumor for over one hour. Sentinel node navigation is one of the important clinical applications for fluorescence nano-particles and silver iodide beads. Our experimental data of those nano-particles in experimental model have shown the potential of fluorescence and X-ray measurement to be alternatives to existing tracers. Future innovation in cancer imaging by nano-technology and novel measurement technology will provide great improvement, not only in clinical field of prevention, diagnosis and treatment of human disease, but also in basic medical science. © 2009 International Federation of Medical and Biological Engineering.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84891955450&origin=inward; http://dx.doi.org/10.1007/978-3-540-92841-6_570; https://link.springer.com/10.1007/978-3-540-92841-6_570; http://www.springerlink.com/index/10.1007/978-3-540-92841-6_570; http://www.springerlink.com/index/pdf/10.1007/978-3-540-92841-6_570; https://dx.doi.org/10.1007/978-3-540-92841-6_570; https://link.springer.com/chapter/10.1007/978-3-540-92841-6_570
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know